One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration

PURPOSE: To report 1-year follow-up of a phase 1/2a clinical trial testing a composite subretinal implant having polarized human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) cells on an ultrathin parylene substrate in subjects with advanced non-neovascular age-related macular...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashani, Amir H., Lebkowski, Jane S., Rahhal, Firas M., Avery, Robert L., Salehi-Had, Hani, Chen, Sanford, Chan, Clement, Palejwala, Neal, Ingram, April, Dang, Wei, Lin, Chih-Min, Mitra, Debbie, Pennington, Britney O., Hinman, Cassidy, Faynus, Mohamed A., Bailey, Jeffrey K., Mohan, Sukriti, Rao, Narsing, Johnson, Lincoln V., Clegg, Dennis O., Hinton, David R., Humayun, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Special Issue
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496407/
https://www.ncbi.nlm.nih.gov/pubmed/34613357
http://dx.doi.org/10.1167/tvst.10.10.13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496407/
https://www.ncbi.nlm.nih.gov/pubmed/34613357
http://dx.doi.org/10.1167/tvst.10.10.13

Ejemplares similares